Evidence map›Paper›PMID 36206739›Full record

ArticleMolecular cell2022

The pausing zone and control of RNA polymerase II elongation by Spt5: Implications for the pause-release model.

Nova Fong, Ryan M Sheridan, Srinivas Ramachandran, David L Bentley

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 74 citations in OpenAlex.

  1. Targeting CDKs in the RNAPII transcription cycle.Nature reviews. Drug discovery · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Kinetic control of mammalian transcription elongation.Nature structural & molecular biology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nova FongRNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, PO Box 6511, Aurora, CO 80045, USA.
Ryan M SheridanRNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, PO Box 6511, Aurora, CO 80045, USA.
Srinivas RamachandranRNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, PO Box 6511, Aurora, CO 80045, USA.
David L BentleyRNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, PO Box 6511, Aurora, CO 80045, USA. Electronic address: david.bentley@cuanschutz.edu.
University of Colorado Denver · US

Funding

Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Trisomy 21 and RNA polymerase II functionR01HD100935 · NICHD · UNIVERSITY OF COLORADO DENVER · PI BENTLEY, DAVID L · 2019 to 2019
$2.8M
Coupling of transcription elongation and termination with pre-mRNA processingR35GM144336 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DAVID L BENTLEY · 2022 to 2026
$2.5M
Coupling of transcription with nascent pre-mRNA metabolismR35GM118051 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BENTLEY, DAVID L · 2016 to 2020
$2.2M
Maintenance of cellular memory through replicationR35GM133434 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI RAMACHANDRAN, SRINIVAS · 2019 to 2023
$2.0M
NIAID NIH HHS T32 AI074491NICHD NIH HHS R01 HD100935NIGMS NIH HHS R35 GM118051NIGMS NIH HHS R35 GM133434NIGMS NIH HHS R35 GM144336
6 · The paper itself

Abstract

The pause-release model of transcription proposes that 40-100 bases from the start site RNA Pol II pauses, followed by release into productive elongation. Pause release is facilitated by the PTEFb phosphorylation of the RNA Pol II elongation factor, Spt5. We mapped paused polymerases by eNET-seq and found frequent pausing in zones that extend ∼0.3-3 kb into genes even when PTEFb is inhibited. The fraction of paused polymerases or pausing propensity declines gradually over several kb and not abruptly as predicted for a discrete pause-release event. Spt5 depletion extends pausing zones, suggesting that it promotes the maturation of elongation complexes to a low-pausing state. The expression of mutants after Spt5 depletion showed that phosphomimetic substitutions in the CTR1 domain diminished pausing throughout genes. By contrast, mutants that prevent the phosphorylation of the Spt5 RNA-binding domain strengthened pausing. Thus, distinct Spt5 phospho-isoforms set the balance between pausing and elongation.

Indexed as

RNA Polymerase IITranscriptional Elongation FactorsPeptide Elongation FactorsPhosphorylationTranscription, GeneticPeptide Elongation FactorsRNA Polymerase IITranscriptional Elongation FactorsDRBNET-seqpause-release modelSpt5Spt5 phosphorylationtranscriptional pausingtranscription elongation

Identifiers

PMID36206739
PMCPMC9555879
OpenAlexW4302424778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.